1)Fearnley JM, et al:Ageing and Parkinson's disease:substantia nigra regional selectivity. Brain 114:2283-2301, 1991
2)Jankovic J:Progression of Parkinson disease:are we making progress in charting the course? Arch Neurol 62:351-352, 2005
3)Braak H, et al:Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211, 2003
4)Hely MA, et al:The Sydney multicenter study of Parkinson's disease:the inevitability of dementia at 20 years. Mov Disord 23:837-844, 2008
5)Ganga G, et al:Longitudinal study of levodopa in Parkinson's disease:effects of the advanced disease phase. Mov Disord 28:476-481, 2013
6)Fahn S, et al:Parkinson Study Group. Levodopa and the progression of Parkinson's disease. N Engl J Med 351:2498-2508, 2004
7)Calabresi P, et al:Levodopa-induced dyskinesias in patients with Parkinson's disease:filling the bench-to-bedside gap. Lancet Neurol 9:1106-1117, 2010
8)Ondo WG, et al:Selegiline orally disintegrating tablets in patients with Parkinson disease and“wearing off”symptoms. Clin Neuropharmacol 30:295-300, 2007
9)Crosby N, et al:Amantadine in Parkinson's disease. Cochrane Database Syst Rev:CD003468, 2003
10)Mallet N, et al:Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats. J Neurosci 26:3875-3884, 2006
11)Moro E, et al:Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 25:578-586, 2010
12)Bejjani, BP, et al:Axial parkinsonian symptoms can be improved:the role of levodopa and bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 68:595-600, 2000
13)Yamada K, et al:Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease. Acta Neurochir(Wien)150:15-22, 2008
14)St George RJ, et al:A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD. Neurology 75:1292-1299, 2010
15)Umemura A, et al:Predictive factors affecting early deterioration of axial symptoms after subthalamic nucleus stimulation in Parkinson's disease. Parkinsonism Relat Disord 16:582-584, 2010
16)Fasano A, et al:Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain 133:2664-2676, 2010
17)Witt K, et al:Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson‘s disease:a randomised, multicentre study. Lancet Neurol 7:605-614, 2008
18)Yamanaka T, et al:Temporary deterioration of executive function after subthalamic deep brain stimulation in Parkinson's disease. Clin Neurol Neurosurg 114:347-351, 2012
19)Voon V, et al:Deep brain stimulation:neuropsychological and neuropsychiatric issues. Mov Disord 14:Suppl S305-27, 2006
20)Jankovic J, et al:Variable expression of Parkinson's disease:a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40:1529-1534, 1990
21)Michal/owska M, et al:Falls in Parkinson's disease. Causes and impact on patients' quality of life. Funct Neurol 20:163-168, 2005
22)Schaafsma JD, et al:Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease. Eur J Neurol 10:391-398, 2003
23)Giladi N, et al:Freezing phenomenon in patients with parkinsonian syndromes. Mov Disord 12:302-305, 1997
24)Mitoma H, et al:24-hour recording of parkinsonian gait using a portable gait rhythmogram. Intern Med 49:2401-2408, 2010
25)Utsumi H, et al:. Quantitative assessment of gait bradykinesia in Parkinson's disease using a portable gait rhythmogram. Acta Med Okayama 66:31-40, 2012
26)Horak FB, et al:The Balance Evaluation Systems Test(BESTest)to differentiate balance deficits. Phys Ther 89:484-498, 2009
27)Bloch F, et al:Parkinson's disease with camptocormia. J Neurol Neurosurg Psychiatry 77:1223-1228, 2006
28)Furusawa Y, et al:Role of the external oblique muscle in upper camptocormia for patients with Parkinson's disease. Mov Disord 27:802-803, 2012
29)Takakusaki K, et al:Role of basal ganglia-brainstem pathways in the control of motor behaviors. Neurosci Res 50:137-151, 2004
30)Karachi C, et al:Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest 120:2745-2754, 2010
31)高草木薫,他:運動下行路―網様体脊髄路.Clin Neurosci 27:752-756,2009
32)Giladi N, et al:Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 6:165-170, 2000
33)日本神経学会ホームページ:パーキンソン病治療ガイドライン2011 http://www.neurology-jp.org/guidelinem/pdgl/sinkei_pdgl_2011_12.pdf(2013年9月15日アクセス)
34)Nieuwboer A, et al:Cueing training in the home improves gait-related mobility in Parkinson's disease:the RESCUE trial. J Neurol Neurosurg Psychiatry 78:134-140, 2007
35)Arias P, et al:Effect of rhythmic auditory stimulation on gait in parkinsonian patients with and without freezing of gait. PLoS One 5:e9675, 2010
36)Frazzitta G, et al:Rehabilitation treatment of gait in patients with Parkinson's disease with freezing:a comparison between two physical therapy protocols using visual and auditory cues with or without treadmill training. Mov Disord 24:1139-1143, 2009
37)Cubo E, et al:Short-term and practice effects of metronome pacing in Parkinson's disease patients with gait freezing while in the 'on' state:randomized single blind evaluation. Parkinsonism Relat Disord 10:507-510, 2004
38)Vandenbossche J, et al:Freezing of gait in Parkinson disease is associated with impaired conflict resolution. Neurorehabil Neural Repair 25:765-773, 2011
39)Doherty KM, et al:Postural deformities in Parkinson's disease. Lancet Neurol 10:538-549, 2011
40)Wunderlich S, et al:Camptocormia in Parkinson's disease mimicked by focal myositis of the paraspinal muscles. Mov Disord 17:598-600, 2002
41)Furusawa Y, et al:Role of the external oblique muscle in upper camptocormia for patients with Parkinson's disease. Mov Disord 27:802-803, 2012
42)Azher SN, et al:Camptocormia:pathogenesis, classification, and response to therapy. Neurology 65:355-359, 2005
43)von Coelln R, et al:Ultrasound-guided injection of the iliopsoas muscle with botulinum toxin in camptocormia. Mov Disord 23:889-892, 2008
44)Tassorelli C, et al:Pisa syndrome in Parkinson's disease:clinical, electromyographic, and radiological characterization. Mov Disord 27:227-235, 2012
45)Vitale C, et al:Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion. Mov Disord 26:1458-1463, 2011
46)Santamato A, et al:Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease. J Neurol 257:139-141, 2010
47)Wright WG, et al:Axial kinesthesia is impaired in Parkinson's disease:effects of levodopa. Exp Neurol 225:202-209, 2010
48)Smania N, et al:Effect of balance training on postural instability in patients with idiopathic Parkinson's disease. Neurorehabil Neural Repair 24:826-834, 2010
49)Mak MK, et al:Cued task-specific training is better than exercise in improving sit-to-stand in patients with Parkinson's disease:A randomized controlled trial. Mov Disord 23:501-509, 2008
50)Cakit BD, et al:The effects of incremental speed-dependent treadmill training on postural instability and fear of falling in Parkinson's disease. Clin Rehabil 21:698-705, 2007
51)Protas EJ, et al:Gait and step training to reduce falls in Parkinson's disease. NeuroRehabilitation 20:183-190, 2005
52)Li F, et al:Tai chi and postural stability in patients with Parkinson's disease. N Engl J Med 366:511-519, 2012
53)Reuter I, et al:Effects of a flexibility and relaxation program, walking, and Nordic walking on Parkinson's disease. J Aging Res:232473, 2011
54)Allen NE, et al:Balance and falls in Parkinson's disease:a meta-analysis of the effect of exercise and motor training. Mov Disord 26:1605-1615, 2011